Company Earnings UpdateLoblaw (TSX: L) 2Q19 Results: Food Growth Softens Coresight Research July 25, 2019 Executive Summary In 2Q19, ended June 15, Loblaw reported a meaningful weakening of comparable sales growth in its food segment. Food retail comp growth of 0.6% compared to 2.0% in the prior quarter and was well below company-measured food-price inflation of 3.6%. Drug retail comp growth strengthened to 4.0% in 2Q19, from 2.2% in the prior quarter. Management maintained FY19 guidance for positive same-store sales and a stable gross margin in the retail segment. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Earnings Insights 4Q24, Week 1: Levi Strauss, P&G, Walgreens and Others Post Sales Growth, While Burberry and Kimberly-Clark Report DeclinesConsumer Sentiment Steadies; Plus, Off-Price and Dollar-Store Shopping in Focus: US Consumer Survey InsightsAnalyst Corner: Three Themes Transforming US Apparel and Footwear Retail in 2025, with Anand KumarWeekly US Store Openings and Closures Tracker 2025, Week 16: 7-Eleven To Close 300+ Stores; Plus Updates on Drugstore Closures
